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The In vitro Antibiotic Tolerant
Persister Population in Burkholderia
pseudomallei is Altered by
Environmental Factors
William C. Nierman*, Yan Yu and Liliana Losada
Infectious Diseases Program, J. Craig Venter Institute, La Jolla, CA, USA
Bacterial persistence due to antibiotic tolerance is a critical aspect of antibiotic treatment
failure, disease latency, and chronic or reemergent infections. The levels of persisters is
especially notable for the opportunistic Gram-negative pathogens from the Burkholderia
and Pseudomonas genera. We examined the rate of drug tolerant persisters in
Burkholderia pseudomallei, Burkholderia thailandensis, Burkholderia cepacia complex
organisms, and Pseudomonas aeruginosa at mid-log growth in LB broth culture. We
found that a fraction of the antibiotic-sensitive cells from every species were tolerant to a
24 h high-dose antibiotic challenge. All tested Burkholderia strains demonstrated a drug
tolerant persister population at a rate that was at least 100–500 times higher than P.
aeruginosa. When challenged with at least a 10X minimum inhibitory concentration (MIC)
24 h exposure to three different antibiotics with different modes of action we found that
in B. pseudomallei Bp82 each of the tree antibiotics revealed different persister fractions
at each of two different growth states. This observation suggests that our assay is
detecting heterogeneous persister subpopulations. Persistence in B. pseudomallei Bp82
was highly dependent on growth stage, with a surprisingly high persister fraction of>64%
of the late stationary phase cells being antibiotic tolerant to 100XMIC cefotaxime.
Adaptation of B. pseudomallei to distilled water storage resulted in a population of drug
tolerant cells up to 100% of the non-drug-challenged viable cell count in the same
cefotaxime assay. Cultivation of B. pseudomallei with a sub-inhibitory concentration of
several antibiotics resulted in altered persister fractions within the population relative
to cultures lacking the antibiotic. Our study provides insight into the sensitivity of the
persister fraction within the population of B. pseudomallei due to environmental variables
and suggests diversity within the persister population revealed by different challenge
antibiotics.
Keywords: melioidosis, disease recurrence, antibiotic tolerance, persister fraction, microbiology, environmental
signals
INTRODUCTION
The emergence of resistant organisms was reported soon after the introduction of antibiotics
into clinical practice (Abraham and Chain, 1940). Similarly, the inability of antibiotic treatment
to sterilize wounds thus resulting in recurrent infections after completion of the treatment
was reported slightly later (Bigger, 1944). The ability of a small subpopulation of bacteria that
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survives a lethal antibiotic challenge is termed persistence or
drug tolerance. This phenomenon is distinct from resistance in
that once these drug tolerant cells resume normal growth after
the drug is removed; they exhibit the same drug sensitivity as
the population originally treated. Unlike resistance, persistence is
not heritable. For reviews of persistence see (Lewis, 2010; Cohen
et al., 2013). Increasing evidence suggests that drug tolerance
or persistence is in fact an actively maintained state, triggered
and enabled by a network of intracellular stress responses that
result in drug tolerance in a fraction of the microbial isogenic
population (Lewis, 2010).
A subpopulation of persister cells is generated spontaneously
in an actively growing population. This persister fraction
can be modified by environmental stresses. This spontaneous
phenotypic dichotomy is thought to result from redundant stress
responses but includes stochastic variation in gene expression
mediated by two gene toxin/antitoxin (TA) systems. When the
toxin is in excess, the persister fraction in the bacterial population
is increased (Maisonneuve et al., 2011). B. pseudomallei has
several TA gene pairs and one has been demonstrated to play a
role in determining the persister fraction in a bacterial population
(Butt et al., 2013, 2014). A number of environmental stresses
can modulate the level of persistence in an isogenic microbial
population. These stresses include heat (Cardoso et al., 2010),
oxidative stress and associated DNA damage (Dörr et al., 2009;
Vega et al., 2012; Wu et al., 2012), cell membrane stress (Poole,
2012), quorum sensing signaling (Vega et al., 2012), carbon
source transitions and nutrient stress (Nguyen et al., 2011), and
cells in biofilms (Keren et al., 2004a).
Burkholderia pseudomallei causes a severe systemic infection
named melioidosis. Melioidosis is endemic in tropical regions
of South East Asia and northern Australia. Melioidosis
can reemerge months to years after apparently successful
antibiotic treatment (Cheng and Currie, 2005). Surviving
melioidosis confers no immunity to subsequent challenge with
the same agent nor are there vaccines that are protective
against melioidosis (Brett and Woods, 2000). In particular,
B. pseudomallei is a category B NIAID priority pathogen and is
listed as a tier 1 HHS and USDA select agent (tier 1—presents
the greatest risk of deliberate misuse with the most significant
potential formass casualties or devastating effects to the economy
critical infrastructure, Choi et al., 2008).
Infections caused by Burkholderia cepacia complex bacteria
are difficult to eradicate with antibiotics, especially in cystic
fibrosis patients due to the rapid development of antibiotic
resistance and/or evasion of treatment via the establishment of
biofilms.
A major concern in the management of disease caused by
these organisms is that an aggressive antibiotic regimen is
required due to the inherent resistance of Burkholderias to
aminoglycoside and macrolide antibiotics (Moore et al., 1999).
In addition, an important feature of these diseases—especially
melioidosis—is that recurrence is common even after completion
of antibiotic treatment and apparent clearing of the bacteria,
occurring in 3–25% of patients (Cheng and Currie, 2005;
Hayden et al., 2012). Molecular typing indicates that most cases
of relapse are due to recrudescence of the original infecting
strain. Prolonged therapy has been shown to reduce relapse
but the multi-drug aggressive therapy is associated with a high
rate of adverse side-effects. A similar recurrent phenotype is
observed in Burkholderia cepacia complex and P. aeruginosa
infections in cystic fibrosis (Drevinek and Mahenthiralingam,
2011). Of importance to military health and biodefense are the
risk of antibiotic failure and subsequent disease recurrence in
melioidosis. While its etiologic agent, B. pseudomallei, poses a
bioterrorism threat, it also poses a significant health risk for active
duty personnel and veterans returning from endemic regions,
especially the risk of late-onset melioidosis that can occur as late
as 62 years after deployment (Cheng and Currie, 2005; Ngauy
et al., 2005).
These recurrent and latent infections are likely caused by
failure to eradicate the organism during an initial infection,
which could in turn result from a non-replicating or slow-
growing persister cell subpopulation that are tolerant to
antibiotics. Some studies in other bacteria suggest that persister
cells evade antibiotic therapy and/or the immune system either by
forming a physical barrier (biofilm) or by developing reversible
mutations that switch off the expression of non-essential genes
(Percival et al., 2011; Keren et al., 2012; Lewis, 2012). Evidence
largely supports that persister cells are metabolically dormant
members of a vegetative population of metabolically active cells
(reviewed in Wood et al., 2013). Persisters are thought to exist
as dormant variants of bacterial cells in a growing population,
a state generated by a stochastic process (Lewis, 2010; Mulcahy
et al., 2010). Due to their slow or non-existent metabolism,
bacterial persisters are tolerant of antibiotic exposure (Gefen
and Balaban, 2009; Lewis, 2010), yet are not antibiotic resistant
due to mutations. The SOS response (Dörr et al., 2009), genetic
mutations (Moyed and Bertrand, 1983; Dörr et al., 2010), and
even growth states (Keren et al., 2004a) are known to increase
the level of persister cells in a population.
Several studies argue that the persister state is an active stress
response of bacterial cells (Nguyen et al., 2011; Khakimova et al.,
2013; Orman and Brynildsen, 2013). Perhaps in reality an active
stress response is in play that ultimately achieves a persister state
typically characterized by low levels of metabolic activity.
In this work we examined the persistence and emergence of
tolerance to antimicrobials in several species of Burkholderia
and in P. aeruginosa strain PA14. As a way of initiating a
study of the regulatory infrastructure of the persister state in
B. pseudomallei, we have undertaken experiments to identify
environmental stressors that alter the persister fraction in a
population of Burkholderia pseudomallei cells. We found that
the persister fraction in B. pseudomallei cultures is modulated by
environmental factors or an antibiotic challenge, and that they
exhibit an extraordinarily high rate of drug tolerant persister cells
in response to challenge by severe nutritional deprivation.
MATERIALS AND METHODS
Bacterial Strains and Culture Conditions
B. pseudomallei Bp82 (Propst et al., 2010), a 1purM mutant
that is avirulent in immunocompetent and immunodeficient
animals and is exempt from select-agent rules, was obtained
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from H. Schweizer. B. cenocepacia BC7, K56-2S, K56-2V (Varga
et al., 2013) were obtained from J. Goldberg. B. multivorans
CGD1 and CGD2 (Varga et al., 2012) were obtained from
S. Holland. B. thailandensis E264 (Yu et al., 2006) was obtained
from D. DeShazer. For Burkholderia, routine medium was Miller
LB (Atlas, 2010) broth and agar. Pseudomonas aeruginosa PA14
(He et al., 2004) liquid medium was Miller LB (Atlas, 2010).
Ciprofloxacin was obtained from MP Biomedicals (Aurora,
Ohio, United States). Levofloxacin, Trimethoprim, Doxycycline,
Gentamicin, and Cefotaxime were obtained from Sigma (St.
Louis, MO). All bacteria were grown at 37◦C in ambient air.
Minimum Inhibitory Concentration
Determination
Minimum inhibitory concentrations (MIC) for antibiotics were
determined by broth microdilution following standard NCCLS
protocols (Institute, 2006) modified to use LB broth medium.
In each case, the MIC was determined to be the concentration
at which no visible growth was observed. The MICs for
B. pseudomallei Bp82 in LB broth culture are: cefotaxime
4µg/mL, ciprofloxacin 2µg/mL, gentamicin 32µg/mL,
chloramphenicol 4.2µg/mL, trimethoprim 4.7µg/mL, and
doxycycline 0.5µg/mL.
Persister Fraction Determination
The assay for determination of the persister fraction in a bacterial
population was adapted from that of R.W. Titball (Hemsley
et al., 2014) as follows. The bacterial culture being analyzed is
pelleted by centrifugation and resuspended to a standard OD600
of 1 (∼109 CFU/mL) in fresh LB medium. The viable colony
forming unit (CFU) concentration of the resuspended bacterial
culture is obtained by serial dilution, plating, and counting
of the colonies after 2 days at 37◦C on LB agar plates. The
fraction of drug tolerant cells within the resuspended population
is determined by exposing the bacterial culture to antibiotics
using a concentration of 100X the MIC for cefotaxime and 10X
theMIC for ciprofloxacin and gentamicin employed in this assay.
The bacterial culture in fresh medium at the above cell density
was combined with the antibiotic and placed in wells (500µl per
well) of a 48 well flat bottom microtiter plate (Corning Costar
3548). The plate is incubated without shaking at 37◦C for 24 h
in an incubator with ambient air. At the end of the incubation
period the samples were transferred to microcentrifuge tubes
and centrifuged for 5min at maximum speed in a bench
top centrifuge to pellet the cells. The antibiotic containing
supernatant was removed and the cells were resuspended in
500µl fresh LB medium as a wash step. The cells are again
pelleted and resuspended in 500µl fresh LB medium. Viable
CFU counts after the antibiotic challenge are obtained by serial
dilutions, plating, and counting as for the total viable CFU
count before the antibiotic challenge. The drug tolerant persister
fraction was the number of cells that survived the antibiotic
challenge divided by the number of cells placed into the well
based on the pre-drug challenge viable CFU count. All assays
were performed in biological triplicate. The persister fractions
and CFU counts reported are the mean value of the three
replicates. The error bars represent the standard deviation (SD)
over the mean from at least three independent experiments.
Antibiotic resistant cells were quantified by plating on solid
medium under 50X MIC antibiotic selection.
Growth in the Presence of 0.25 X MIC
Levels of Antibiotics
In order to explore the effect on the persister fraction
in a population of B. pseudomallei Bp82 cells grown in
liquid LB culture with shaking in the presence of sub-
inhibitory concentrations of antibiotics, an overnight culture
of Bp82 was used to inoculate 50mL of LB broth in 250mL
Erlenmeyer flasks. The flasks contained 0.25 X MIC of one
of the following antibiotics: chloramphenicol, trimethoprim,
doxycycline, cefotaxime, and ciprofloxacin, or no antibiotic as
the reference controls. The initial inoculum was such that three
doublings were required to achieve the targeted final OD600
which for chloramphenicol, trimethoprim, and doxycycline was
0.1 and for cefotaxime, and ciprofloxacin was 2. The flasks were
then incubated at 37◦C in a shaker incubator at 200 rpm. The
OD was monitored during growth and when the target OD was
attained, a persister assay using a 100X cefotaxime challenge
was performed as described. Each experiment was performed in
biological triplicate.
RESULTS
Determination and Characterization of
Persister Fraction within Bacterial
Populations in Liquid Culture for
Burkholderia spp. and Pseudomonas
aeruginosa
Based on previous studies in Burkholderia spp. and
Pseudomonas aeruginosa of disease recurrence (Drevinek and
Mahenthiralingam, 2011) and extreme long term viability under
nutrient restriction including distilled water for B. pseudomallei
(Moore et al., 2008; Hamad et al., 2011), we hypothesized that
members of the Burkholderia genus compared to Pseudomonas
aeruginosa PA14 were likely to enter a persister state within a
population of in vitro growing cells at mid-log phase growth
at a high measurable frequency. We tested six different
isolates of Burkholderia cepacia complex, B. pseudomallei and
B. thailandensis, and P. aeruginosa to determine their ability and
frequency of entry into a persister state as assayed by tolerance
to a high levels antibiotic challenge. Exponentially growing cells
were exposed to levofloxacin (a fluoroquinolone) at 10-fold
(10X) the MIC and persister cells were enumerated as those that
were viable after at least 16 h post-antibiotic treatment (Mulcahy
et al., 2010). All tested Burkholderia spp. had between 0.05 and
0.25% of the population as persister cells—a rate that was at
least 100–500 times higher than wild-type P. aeruginosa PA14
(Table 1). The rates for Burkholderia species were comparable
to the P. aeruginosa high persister phenotype as described
(Mulcahy et al., 2010). In order to ascertain whether these
cells were viable because of antibiotic resistance, and not due
to tolerance, antibiotic-exposed cultures were plated in both
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TABLE 1 | Rates of persisters for Burkholderia spp. and Pseudomonas
aeruginosa in liquid culture mid-log growth assayed by challenge with
10X MIC levofloxacin.
Species and strain MIC (µg/mL) Persister rate (%)
B. multivorans CF1 16 0.085
B. multivorans CF2 16 0.5
B. multivorans CGD1 16 0.26
B. multivorans CGD2 16 0.25
B. cenocepacia K56-2V 4 0.19
B. cenocepacia K56-2S 4 0.05
B. cenocepacia BC7 16 0.02
B. thailandensis E264 4 0.14
B. pseudomallei Bp82 4 0.11
P. aeruginosa PA14 0.25 0.0007
FIGURE 1 | Viable Bp82 CFUs vs. duration of exposure to 100X MIC
cefotaxime without shaking. Actively growing shaking cultures of Bp82 in
liquid LB medium at 37◦C were allowed to attain an OD600 of 1.4. The cells
were pelleted by centrifugation and resuspended to an OD of 1 in fresh LB
medium. The total viable CFU/mL concentration of the population was
determined by serial dilution and plating (0 h). Aliquots, 0.5mL, of the culture
were placed into multiple wells of a 48-well flat bottom microtiter plate with
cefotaxime at 100X MIC (400µg/mL) and the plate was placed in a 37◦C
incubator for the indicated times without shaking. The contents of triplicate
wells were evaluated for the remaining surviving bacteria as determined by
serial dilution and plating at each indicated time point. The figure represents
the results of three biological replicates. The error bars represent the standard
deviation (SD) over the mean from at least three independent experiments.
selective (50X MIC) and non-selective media for enumeration.
Fewer than 1 in 108 cells of the antibiotic-tolerant cells grew
under selection, demonstrating a very low rate of conventional
antibiotic resistance.
The Time Dependent Killing of
B. pseudomallei BP82 under High
Antibiotic Dosage Challenge Reveals a
Time Interval with Sufficient Viable CFU
Stability for Enumerating the Persister
Fraction of a Population
The goal of our study is to identify some environmental factors
that influence the persister fraction within a B. pseudomallei Bp82
population. The assay for determination the persister fraction
FIGURE 2 | Viable Bp82 CFUs vs. duration of exposure to 100X MIC
cefotaxime with shaking. Actively growing shaking cultures of Bp82 in liquid
LB medium at 37◦C were grown to attain an OD600 of 0.1. The total viable
CFU/mL concentration of the population was determined by serial dilution and
plating (0 h). Cefotaxime was added to 100X MIC (400µg/mL) and the culture
was returned to shaking at 37◦C. At the indicated times, 0.5mL aliquots were
removed to determine the viable CFU/mL concentration by dilution and plating
after removal and replacement of the antibiotic containing medium. The figure
represents the results of three biological replicates. The error bars represent
the standard deviation (SD) over the mean from at least three independent
experiments.
in a bacterial population was adapted from that of R.W. Titball
(Hemsley et al., 2014). The fraction of the cells in the persister
state within a population is determined by the dilution and
plating of the cells in the population to obtain a total vial CFU
count per mL of culture followed by determining the viable CFU
count per mL that survives a high dose antibiotic challenge. The
persister fraction is calculated by calculating the fraction of the
total viable population that survives the antibiotic challenge. The
assay uses a 100X MIC dose of cefotaxime on bacterial cells
resuspended in fresh LB medium at an OD600 = 1, thus assuring
that the cells are not in stationary phase. While the details of
the assay are described in Materials and Methods, we needed to
establish the duration of the antibiotic challenge for Bp82 so we
determined a time course of the viable CFU decline under the
antibiotic challenge under the conditions of the assay. As shown
in Figure 1, after the initial decline in the CFU viability due to the
antibiotic killing of the non-persister members of the bacterial
population, the CFU viability is stable from 24 h of antibiotic
exposure until at least 33 h.
The persister cefotaxime challenge assay we use based on the
findings shown in Figure 1 accomplishes the antibiotic challenge
in microplate wells without shaking. We modified the antibiotic
challenge format by growing shaking cultures of Bp82 in LB
liquid medium to an OD600 of 0.1 and removing an aliquot
for total viable CFU determination followed by the addition
of cefotaxime to a concentration of 400µg/mL. Shaking was
continued at 37◦C and aliquots were taken at the times indicated
in Figure 2 to obtain the surviving CFU/mL count at that
time point during the antibiotic challenge. As shown in the
figure, in contrast to a surviving persister population surviving
antibiotic challenge after 24 h without shaking (Figure 1), when
the antibiotic challenge is accomplished in a shaking culture,
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no viable bacterial cells remain at this time point. The most
obvious difference in the two challenge conditions is the
limitation of oxygen available to the cells not being shaken.
Hemsley et al. (2014) reported that drug-tolerant Burkholderia
cells are characterized by an anaerobic metabolic signature. It
is likely that the ready availability of oxygen in the shaking
culture resulted in pulling the initial persister population from
this state over the 24 h challenge time course resulting in
antibiotic killing of the entire population. The shake culture
experiment was repeated using a 10X gentamicin challenge.
A similar profile of the CFU decline was observed with no
viable cells remaining at 24 h into the challenge (data not
shown).
The Use of Different Antibiotics in the
Persister Challenge Assay Enumerates a
Different Fraction of the Population as
Persisters
We then tested whether antibiotic tolerance in B. pseudomallei
Bp82 was independent of the antibiotic used in the persister
assay and could thus potentially reemerge after treatment
with clinically-relevant antibiotics. To this end, we performed
persister assays using 100X cefotaxime and 10X ciprofloxacin and
gentamicin. The assays were conducted at two different points
in the growth curve, one at an OD600 of 0.1 and the other at an
OD600 of 2.1. The observed persister fraction at each of the two
time points was replicated using all three of the antibiotics in the
persister assay (Figure 3).
Challenge with 100X MIC cefotaxime revealed a persister
fraction of 0.11 and 0.57 at OD600 of 0.1 and 2.1 respectively;
with 10X MIC gentamicin the corresponding persister fractions
were 0.007 and 0.085; and with 10X MIC ciprofloxacin they
were 0.00059 and 0.004. The lower frequency of drug tolerant
persisters revealed by challenge with ciprofloxacin has been
previously reported (Hemsley et al., 2014). Two observations are
of note relative to these data. The first is that the persister fraction
is higher at the later growth phase point, OD600 = 2.1, than at the
earlier point of OD600 = 0.1. The second is that depending on
the antibiotic used in the challenge, the fraction of persisters in
the populations analyzed is quite different, suggesting that each
antibiotic is selecting a different but likely overlapping persister
subpopulation.
The Persister Fraction is Influenced by
Some Antibiotics
While not directly known to alter the rate of persisters within
a bacterial population, bacterial antibiotic therapy alone has
been shown to increase the rate of spontaneous mutations
(Kohanski et al., 2010). Bacteria exposed to sub-inhibitory doses
of antibiotics have been demonstrated to exhibit mutations
through production of reactive oxygen species and through
activations of the error-prone DNA polymerase PolIV (Gutierrez
et al., 2013; Nair et al., 2013). Resistance mutations can be
selected under such minimal drug pressure (Gullberg et al.,
2011). We have undertaken an evaluation of the potential
for antibiotics employed in melioidosis therapy (Schweizer,
2012) to alter the persister rate in in vitro culture populations
of Bp82. The antibiotics we employed in the study are
FIGURE 3 | Persister fractions determined at two OD600 growth states using three different antibiotics for persister selection.
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TABLE 2 | Cultivation of B. pseudomallei in the presence or absence of
0.25 X MIC of listed antibiotics.
Antibiotic Bp82 + Antibiotic Bp82 − Antibiotic
Persister fraction Persister fraction
Chloramphenicol 0.11 0.1
Trimethoprim 0.32 0.07
Doxycycline 0.03 0.08
Cefotaxime 0.31 0.43
Ciprofloxacin 0.18 0.43
chloramphenicol, trimethoprim, doxycycline, ceftazidime and
ciprofloxacin. We have determined the Bp82 MIC for these
antibiotics by broth microdilution following standard NCCLS
protocols (Institute, 2006). These MICs are provided in Materials
and Methods.
We targeted an early log phase growth point (OD600 = 0.1)
for 0.25X MIC chloramphenicol, trimethoprim, and doxycycline
cultivation and at late log phase point (OD600 = 2) for cefotaxime
and ciprofloxacin cultivation in LB broth shaking cultures at
37◦C for evaluating the consequence on the persister fraction of
cultivation in the presence of the sub-inhibitory levels for each of
the antibiotics tested. Briefly, an overnight culture of Bp82 grown
in the presence and absence of the antibiotic under consideration
was diluted in the morning to require three doublings in the
presence of antibiotics before initiating the standard cefotaxime
persister challenge assay described in Materials and Methods.
No-antibiotic controls were treated in the same way. Growth was
monitored by OD reading until the target ODs were attained.
The persister fractions obtained with and without antibiotic were
compared to quantify the consequence, if any, for the cultivation
in the presence of the antibiotic. As before, all experiments were
performed in triplicate. While cultivation in the presence of the
0.25 X MIC levels of chloramphenicol did not influence the
resulting persister fraction, the trimethoprim cultivation greatly
increased the persister fraction while cultivation in the presence
of doxycycline, cefotaxime, and ciprofloxacin resulted in persister
fractions lower that that observed in the absence of the antibiotic
(Table 2).
Environmental Factors that Influence the
In vitro Persister Population
To understand whether growth conditions affected
B. pseudomallei Bp82 persister cell induction, we studied
the fraction of cefotaxime tolerant cells (at 100X MIC) as a
function of growth stage. As noted earlier, we found that the
fraction of the population exhibiting the persistence phenotype
fraction increased as the growth cycle progressed through the
log phase and into the stationary phase of growth (Figure 3).
This growth phase dependence of the persister fraction in Bp82
is very similar to that reported for Burkholderia thailandensis
(Hemsley et al., 2014). The antibiotic tolerance phenotype in B.
pseudomallei was not due to increased antibiotic resistance, as
cells plated on selective media containing 20X MIC cefotaxime
after surviving the persister assay antibiotic challenge did
TABLE 3 | Evaluation of persister fraction during very extended LB broth
culture.
Cultivation day CFU/mL before CFU/mL after Persister
selection selection rate
5 6.8 E 8 3.3 E 7 0.05
10 1.3 E 9 2.3 E 7 0.018
11 2.2 E 8 4.6 E 6 0.021
12 1.6 E 8 7.6 E 7 0.48
13 5.2 E 6 3.4 E 6 0.65
14 2.8 E 5 1.3 E 5 0.46
not grow. Our results showed that antibiotic tolerance and
persistence in B. pseudomallei Bp82 exhibits a similar phenotype
to the persister phenotype observed in a fully virulent B.
pseudomallei strains (Butt et al., 2013).
Environmental Factors that Maximize the
Persister Fraction
Late Stationary Growth Phase
B. pseudomallei Bp82 was cultured in LB broth to the late
stationary growth phase to determine the maximum persister
fraction that could be obtained during LB liquid culture. Cultures
were established in triplicate using 50mL conical centrifuge tubes
with a 10mL broth culture volume with shaking at 37◦C. The
cultures were assayed for persister fraction starting from day 5
to as late as day 15. Daily assays were performed from days 10
to 15. The maximum persister fraction attained was 0.65 at day
13 when the viable CFU count had declined to 5.2 × 106 per mL
(Table 3).
Distilled Water Storage
B. pseudomallei is reported to survive in distilled water storage
for 16 years (Pumpuang et al., 2011). Expression profiling and
mutant analysis of B. pseudomallei in distilled water storage
was used to explore genes essential for long term water
survival (Moore et al., 2008). In investigating environmental
factors that may maximize the fraction of persisters in the
population we determined the persister fraction present over
time in a population of Bp82 maintained in distilled water at
ambient room temperature with shaking. An overnight culture
of B. pseudomallei Bp82 colony was used to inoculate triplicate
10mL of LB broth in 50mL conical centrifuge tubes which were
then grown overnight with shaking, achieving an OD600 of 1.8.
The three bacterial cultures were pelleted by centrifugation and
the pellets were resuspended in 10mL distilled water for washing.
The bacteria were again pelleted by centrifugation and again
suspended in 10mL distilled water in each of the three tubes. The
cultures were placed at room temperature with shaking. Persister
assays were performed at intervals to determine the change in
persister fraction in the cultures over time under this storage
condition. The findings are shown in Figure 4. While the level of
viable cells declined over the period of observation, the fraction
of persisters increased achieving a level of 100% persisters in the
population at 34 days.
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FIGURE 4 | Viable colony forming units (CFU) after storage in distilled water Blue is viable cells before antibiotic persister selection and red is viable
cells after antibiotic persister selection. The error bars represent the standard deviation (SD) over the mean from at least three independent experiments.
DISCUSSION
Pathogenic bacterial populations contain a fraction of the
isogenic cells in a state of dormancy that allows them to be
tolerant to a challenge by multiple antibiotics while not being
resistant to the antibiotics through genomic changes conferring
resistance. The drug tolerance associated with this persister
state is achieved through the lack of metabolic activity of the
bacterial target of the antibiotic. For example, in the absence
of cell wall synthesis in a dormant persister cell a β-lactam
antibiotic will not kill the cell since the killing is dependent upon
inhibition of the cell wall synthesis during cellular replication.
In stationary phase cells of P. aeruginosa, Escherichia coli, and
Staphylococcus aureus the fraction of the population in the
persister state can achieve a maximum level of ∼0.01 (Keren
et al., 2004b). In the present study, during mid-log growth several
Burkholderia cenocepacia complex species achieved a persister
fraction between 25 and 50% revealed by levofloxacin challenge,
while the B. pseudomallei Bp82 fraction was 11% and the
P. aeruginosa PA14 fraction was 0.07% (Table 1). As observed for
the ciprofloxacin persister challenge, fluoroquinolone antibiotics
give a lower persister fraction in the assay than the several
other antibiotics (Figure 3). These observations indicate that
some pathogenic members of the Burkholderia genus can achieve
very high persister fraction in mid-log phase culture relative to
E. coli, S. aureus, and P. aeruginosa. The association between
the in vitro high persister fraction potential of B. pseudomallei
and the high rate of reemergent infections in melioidosis patients
after an antibiotic regimen resulting in an apparent cure provides
justification for pursuing in vivo studies for demonstrating a
causal relationship between bacterial drug tolerant persistence,
and latent and reemergent melioidosis episodes.
We have used five antibiotics in conjunction with persister
assays to determine if exposure to sub-inhibitory level of
antibiotics influences the persister fraction in a population of
Bp82 cells. These antibiotics are cefotaxime, a β-lactam inhibitor
of cell wall syntheses; chloramphenicol, a protein elongation
inhibitor of protein synthesis; doxycycline, a tetracycline class
protein synthesis inhibitor that that blocks the attachment of
the charged aminoacyl-tRNA to the ribosome mRNA complex;
trimethoprim, a dihydrofolate reductase inhibitor that blocks
the thymidine synthesis pathway thus inhibiting bacterial DNA
synthesis; and ciprofloxacin, a fluoroquinolone that inhibits DNA
gyrase thus blocking bacterial DNA replication and cell division.
Cultivation of Bp82 in the presence of 0.25X MIC ciprofloxacin
results in a∼2X lower persister fraction than in the absence of the
antibiotic (Table 2), supporting the hypothesis that ciprofloxacin
exposure may reduce the ability of B. pseudomallei to remain in
the persister state or speeds up the transition from the dormant
persister to the vegetative growth state. At 0.25 MIC exposure
to growing Bp82 cells, the persister fraction is also reduced for
cefotaxime and doxycycline while the persister fraction is much
higher in the presence of trimethoprim (Table 2). Cultivation
in chloramphenicol does not alter the persister fraction from
that observed in its absence. Perhaps these persister fraction
altering antibiotics cause changes in the kinetics of the persister-
vegetative cell transitions, thus altering the equilibrium persister
fraction in the population.
The additional topic of focus for the current study is to explore
conditions that may lead to the attainment of a maximum level
of persisters in an in vitro population of Bp82. We first directed
our effort to extendedmaintenance of stationary phase cultures of
Bp82 in LB medium at 37◦C with shaking. As shown in Table 3,
the population of viable cells is in decline for the analyzed 5th
through 14th day of culture. A maximum persister rate of 65% is
attained on day 13.
We next turned our attention to determining the level of
persisters in the population of Bp82 stored in distilled water.
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As noted earlier, B. pseudomallei is notable for its ability to
survive long term storage in distilled water. Our time course in
distilled water was conducted with shaking at room temperature.
As shown in Figure 4, although the viable CFU level in the
distilled water declines continuously during the 7–49 day period,
the absolute level of persisters is stable until the day 34 assay.
Considerable decay in the absolute persister population occurs
between days 34 and 49 (data not shown), although all of the
cells remaining viable in this time window are persisters. Clearly
being in the persister state provides survival advantage to Bp82
cells under the nutritional and osmotic stress of storage in
distilled water. Perhaps this high level of persister formation is
a response in B. pseudomallei to severe stress analogous to the
environmental stress induced initiation of sporulation in some
other bacterial species.
We have identified conditions for obtaining high levels of
persisters in B. pseudomallei during in vitro culture/storage.
We have also characterized the consequence on the persister
fraction in a B. pseudomallei population by in vitro cultivation
with sub-inhibitory levels of 5 antibiotics with different
bacterial mechanisms of action. Additional studies can now be
undertaken with B. pseudomallei populations composed almost
entirely of drug tolerant persister cells for elucidating the
genomic infrastructure that regulates the transitions between
the vegetative growing population members and the dormant
persister members of a culture population. Information on this
issue will provide valuable background before proceeding to
determine if a causative relationship exists between latent and
recurrent B. pseudomallei infections and the potential in vivo
persister status of B. pseudomallei facing a host immune system
challenge coupled with a therapeutic antibiotic intervention.
Once causality is established, the persister infrastructure can
be targeted for drug intervention to suppress the formation of
persisters or to eliminate persisters from the B. pseudomallei
population causing melioidosis in a mammalian or human host,
thus reducing or eliminating recurrent infections.
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